Aura Biosciences secures $8 million in additional funding and augments Board of Directors and Clinical Advisory Board

por Ysios Capital

The round of financing consisted of expanded funding commitments from its existing investors: Advent Partners, Chiesi Ventures, Ysios Capital, Alexandria Venture Investments and several individual inv...

Leer más
Subscribirse al Directorio
Escribir un Artículo

Destacadas

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology

Alantra asesora a Precinmac en la adquis...

by Alantra

Esta operación refuerza la trayectoria de Alantra en el asesoramiento...

Diapositiva de Fotos